Flanvotumab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | HGF |
Identifiers | |
CAS Number |
1188277-05-5 ![]() |
ATC code | None |
ChemSpider | none |
Chemical data | |
Formula | C6470H9986N1714O2018S46 |
Molar mass | 145.5 kg/mol |
![]() ![]() |
Flanvotumab is a human monoclonal antibody designed for the treatment of melanoma.[1]
Flanvotumab was developed by ImClone Systems.
References
- ↑ "Statement On A Nonproprietary Name Adopted By The USAN Council: Flanvotumab" (PDF). American Medical Association.
This article is issued from Wikipedia - version of the Sunday, February 28, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.